Once valued at $1.5 billion, the Silicon Valley-based company founded in 2001 develops ingestible sensors that transmit when medicines are taken, plus a wearable patch reads the response. Proteus had ...
The US healthcare system’s focus on activity rather than value for money was behind the demise of Proteus Digital Health and its “digital pill”, which measured whether schizophrenia patients took ...
Abstract: This paper presents the use of the Proteus environment for the study of Arduino-driven sensor circuits, designed to support electronics student education. A simulation model of sensor ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results